Provided By GlobeNewswire
Last update: Dec 20, 2024
Cash on Hand Utilized to Repay $30 Million of Senior Secured Term Loan Facility to Ares Capital
Lowers ADMA’s Total Debt to $75 Million, a 29% Reduction
Read more at globenewswire.com19.64
-1.67 (-7.84%)
Find more stocks in the Stock Screener
Discover ADMA BIOLOGICS INC, an undervalued growth gem. NASDAQ:ADMA is shining in terms of growth metrics, and it's also displaying strong financial health and profitability, retaining an appealing valuation.